Editorial
 CLOUD OVER CDSCO   
 Thursday, May 17, 2012 
 The Parliamentary Standing Committee on health & family welfare has brought out last week a highly damaging report on the working of India’s apex drug control authority, Central Drug Standard Control Organization. 
  Past Editorial...  
TODAY'S NEWS
16:00  [IST]Neurocrine announces Urocortin 2 phase II study results in acute decompensated heart failure pateints
15:00  [IST]Ceregene Parkinson's disease study shows long-term neurturin expression and enhanced dopamine activity
14:15  [IST]Dishman Pharma net dips by 29% in FY'12
14:00  [IST]Study finds genetic test results do not trigger increased use of health services
13:45  [IST]Unichem Labs net dwindles by 24% to Rs.82 crore
13:00  [IST]NovaBay begins global BAYnovation phase 2b study for adenoviral conjunctivitis
more news >>
TOP NEWS
08:00  [IST]US FDA rules on sterility testing of biologics takes effect on June 4, 2012
08:00  [IST]CLCSS failed to enthuse small and micro enterprises even after relaxing norms
08:00  [IST]Elsevier launches ClinicalKey, an online clinical information resources, to physicians
08:00  [IST]Trade delegation led by commerce minister to visit Brazil to promote pharma trade on June 6
08:00  [IST]Koch Institute sees serious impact of global financial slowdown on growth of research
08:00  [IST]CEMAST set up in Mumbai for training surgeons in minimal access surgery
more news >>
YESTERDAY'S NEWS
18:00  [IST]Researchers create prosthetic retina for AMD patients to restore sight
17:10  [IST]BCG report urges India to promote investment in bioinformatics, translational research
17:00  [IST]Mettler Toledo introduces Rainin AutoRep S manual adjustable repeater pipette
16:50  [IST]IDMA to organize pharma marketing seminar in Chennai on May 19
16:00  [IST]Oramed Pharma'a core technology in oral delivery of proteins gets Israeli patent
15:00  [IST]Elevation Pharma reports positive phase II b results for EP-101 in COPD patients
more news >>
INTERVIEW  
Japan presents significant opportunities for doing business
68012+Greg_Kerwin.jpgGreg Kerwin, Pharma Portfolio Director for UBM Live in an e-mail interview with AD Pradeep Kumar talks about the pharma industry in Japan and the future of CphI Japan events
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Should the D&C Act be further amended to protect bona fide drug manufacturers from being harassed by drug authorities under section 36AC of the Spurious Drugs Act?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
Business of Pharma Marketing
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
 
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |